Quantinno Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Quantinno Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$426K	Sell	3,838 -13	-0.3%	-$1.18K	﹤0.01%	3052
2026 Q1	$335K	Buy	3,851 +20	+0.5%	+$1.95K	﹤0.01%	2976
2025 Q4	$410K	Buy	3,831 +1,273	+50%	+$135K	﹤0.01%	2618
2025 Q3	$258K	Buy	+2,558	New	+$237K	﹤0.01%	2574
2025 Q2	–	Sell	-17,086	Closed	-$905K	–	2623
2025 Q1	$905K	Buy	17,086 +966	+6%	+$53.6K	0.01%	1184
2024 Q4	$902K	Hold	16,120	–	–	0.01%	1077
2024 Q3	$845K	Sell	16,120 -2,000	-11%	-$95.8K	0.01%	989
2024 Q2	$744K	Buy	+18,120	New	+$723K	0.01%	911

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quantinno Capital Management's RYTM Position: Q2 2026 in Review

Quantinno Capital Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 0.34% in Q2 2026, selling an estimated $1.18K and leaving 3,838 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #3052.

Quantinno Capital Management first reported a position in RYTM in Q2 2024 and has held it in 8 quarters since. The position peaked at $905K in Q1 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Quantinno Capital Management held 3,838 shares of Rhythm Pharmaceuticals worth $426K as of Q2 2026.
Quantinno Capital Management sold 13 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $1.18K.
Rhythm Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3052 holding.
Quantinno Capital Management first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Quantinno Capital Management's Rhythm Pharmaceuticals position peaked at $905K in Q1 2025.
304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.